SCOPE

Turkish Journal of Pathology (http://www.turkjpath.org)(ISSN:1018- 5615 / E-ISSN:1309-5730) is the official journal of the Federation of Turkish Pathology Societies and is devoted to the continuing education of national and international practicing pathologists, and to provide a forum for social and scientific communication in the field. The Journal is a peer-reviewed scientific journal published every four months, three times a year (January, May, September), and aims to reach all relevant national and international medical institutions and persons. Articles in English are welcome.

MANUSCRIPT TYPES

Studies that emphasize these aims provide the basis of publication including original articles, reviews, abstracts from annual meetings, letters to the editor, book reviews, biographies and articles with social content.

Turkish Journal of Pathology accepts only invited review articles.

Case series are evaluated as case reports and are not considered as original articles unless they provide novel results or new techniques/biomarkers/molecular studies/prognostic markers etc. that have not previously been reported. In equivocal situtations, the article type is defined by the editor and their decision is final.

Case reports are evaluated for publication only if they describe a new entity, a new or a very rare histopathological and/or molecular characteristic. Case reports that do not fulfill these criteria will be immediately rejected by editorial decision.

ETHICAL CONSIDERATIONS

Articles must be in accordance with the “International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (http://www.icmje.org/).

A submitted article must not have been previously published in print or electronic format and must not be under consideration for publication at another journal or electronic media, and, if accepted, must not be published elsewhere in any languages in a similar form. Studies presented at a meeting or symposium or in electronic form will be considered for publication if this is stated.

If any previously published quoted passages, tables, figures, etc. are used in the article, authors should obtain written permission from the publication rights holders and the authors, and should specify this in the article.

Authors are responsible for their articles’ conformity to ethical rules.

All new submissions are screened for plagiarism by similarity check software (Ithenticate).

• For studies involving human subjects/material/data: The study protocol for human experimentation must conform to ethical guidelines established in the World Medical Association Declaration of Helsinki (http://www.healthscience.net/resources/ declaration-of-helsinki/). Therefore, all articles submitted for publication must specify that the ethic standards of the above committee were adhered to. Authors must specify in the method(s) section that they performed the study according to these principles and that they obtained “approval” from their institution’s ethics committees and informed consent from the participants. Any necessary permission documents from local and International ethic committees or in-stitutional review board (IRB) approval must also be uploaded with the manuscript during the initial submission.
• If the authors claim that the study does not need ethics committee approval, the journal will ask authors for confirmation from an ethics committee indicating that the study does not need ethics committee approval and/or waiver of consent from IRB.
• For studies involving animals: Articles reporting the results of experimental studies on animals must include a statement that study protocol was approved by the animal ethics committee of the relevant institution and that the study was conducted in accordance with “Guide for the Care and Use of Laboratory Animals” (http:// www.nap.edu/catalog/5140.html). Authors must upload the approval of the relevant ethics committee with the manuscript during the initial submission.

THE CONFIDENTIALITY and PRIVACY OF PATIENTS and STUDY PARTICIPANTS

Authors should avoid use of descriptive information such as patient names, initials, reference numbers or full photographs in their manuscript. Such information can be published if absolutely necessary for scientific reasons and only after obtaining written "informed consent" from the patient (or parents, or legal guardian).

For individual case reports, a statement confirming that "informed consent" provided by the patient or a legally authorized representative must be included in the methods section of the manuscript. Authors must also include such a statement in their cover letter. The authors should keep a copy of the written informed consent form and should upload it as a separate file if requested by the Editorial Office.

DECLARATION of CONFLICT of INTERESTS

A conflict of interest is defined as any financial, personal, academically competitive or intellectual relationship between the author, reviewer or editor that involves article submission, referee evaluation, editorial decision and author-referee-editor correspondence and that could lead to a prejudiced and unfair action during the evaluation stage.

Turkish Journal of Pathology requires all authors to acknowledge, on the title page of their manuscript, all funding sources that supported their work, as well as all institutional or corporate affiliations of the authors that might pose a conflict of interest in connection with the submitted manuscript.

The authors must declare any financial relationship or conflict of interest that needs to be known regarding the study. All financial contributions and sponsorships for the study and all financial relationships and conflicts of interest should be included in the title page of the manuscript. The authors must explain the study sponsor’s role in collecting, evaluating and analyzing the data, writing the manuscript and submitting it for publication. If there is no conflict of interest, this section must include a “The authors declare no conflict of interest” statement. All sources of funding should be mentioned in the manuscript.

The evaluation process for the article is not started if a conflict of interest statement is not present at the time the manuscript is submitted. If a conflict of interest becomes apparent after the article is published, the journal may make an official correction or retract the article.

The reviewers also need to declare all their interests that they feel may represent a potential conflict of interest. The reviewers must declare to the editor any conflicts of interest that may prejudice their evaluation of the article and must avoid evaluation of certain articles if a potential prejudice is present.

The editors who will make the final decision on the articles cannot have any personal, professional or financial relationship with any of the authors of the articles they will decide on. The editors will also try to avoid any reviewers who have a possible conflict of interest, for example those working in the same department or facility as any of the authors.

The editors and publisher assume no responsibility regarding features and explanations of any commercial products advertised in the journal.

AUTHORSHIP & CONTRIBUTORSHIP STATEMENT

Every author specified in the manuscript should have properly contributed to the manuscript, should meet the authorship criteria and is responsible for the contributed content. Each section in the manuscript regarding study results and integrity should be the under the responsibility of at least one author. The Turkish Journal of Pathology accepts the criteria of the International Committee of Medical Journal Editors (http://www.icmje.org). The author(s) should accordingly;

1. Make a significant contribution to the planning and design or analysis or interpretation or both of the study,
2. Make a contribution to the writing or revision of scientific content of the manuscript,
3. Approve the final version of the manuscript that is going to be published,
4. Accept responsibility for the appropriate analysis and resolution of questions related to the integrity and accuracy of a section of a study and for all aspects of the study.

For multicenter studies, all declared authors should meet the above authorship criteria. Contribution such as searching for and finding financial support for the study or only collecting data or general help and guidance for those conducting the study do not confer the right to authorship. Individuals who have contributed to the study but do not meet authorship criteria can be included in the “Acknowledgements” section after their consent is obtained. The author order should be the joint decision of all authors. The editor can ask the individual contribution of each author and may find it appropriate to publish this information to prevent an unnecessary increase in the number of authors or unfair academic or similar benefits.

ADVERTISING

The Turkish Journal of Pathology accepts advertising for products and services that are of interest to users professionally. The decision of acceptance is subject to consultation with the journal’s board of directors. The board of directors reserves the right to accept and reject advertising proposals.

REVENUE SOURCES

The sources of income of the Turkish Journal of Pathology include institutional support (Federation of the Turkish Pathology Societies) and display advertising for pharmaceutical and nonpharmaceutical products.

RELATIONS WITH EDITOR(S), AUTHOR(S) AND REVIEWER(S)

Editors do not share information regarding articles (manuscript receipt, review process, reviewer opinions or final results) with anyone except authors and reviewers. Reviewers and editorial board members cannot discuss manuscripts in a public manner. Editors must send copies of the manuscript to the editor-in-chief for final decision once their review is complete. Reviews cannot be printed or disclosed without permission of the author and editor. Care is taken to keep the identities of the reviewers confidential. In some cases, the editor may decide to send the reviewer opinions on the manuscript to other reviewers reviewing the same article to inform them during the process. All manuscripts submitted will be subjected to peer review by the editorial board, and the authors will be informed within four weeks. Editorial board reserves the right to make some revisions in the manuscript. Revised manuscripts should also be accompanied by a unique letter with responses to reviewers' comments. Manuscripts that do not comply with the journal requirements listed below may be returned without review at the discretion of the editors. If the journal requests a revision, the author(s) should submit the revised version within three months. Otherwise, it will be considered a new submission.

CHANGES IN AUTHORSHIP

Corresponding author is responsible for accurate declaration of the author list during the initial submission. Changes to the authorship will not be allowed after the acceptance of the manuscript. Exception is only possible if substantial contribution is provided by an additional co-author during manuscript revision process. In such cases, requests to change the authorship, i.e., to include a co-author must be made by sending an official letter to the editorial office that explains the reason for this change request and signed by all authors to show they agree on the change(s), and the new co-author(s). The final decision is made by the editor.

PREPARATION of MANUSCRIPT

Manuscript should be typed in 12 pt (Times New Roman), double spaced throughout with margins of 2.5 cm, and pages must be numbered on the right bottom of the page. Manuscripts must be in accordance with the International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/).

Original articles should not exceed 15 double spaced typewritten pages, and case reports should not exceed 10 pages. Articles should be sent in either "doc" or "txt" format and organized as follows:

1. Title page: Authors must submit the title page as a separate file. The title page should contain the manuscript title, authors’ names, academic titles and affiliations, a running title not exceeding 40 characters and the address for manuscript correspondence including e-mail address and telephone and fax numbers. If the article was presented at a scientific meeting, a complete statement including the date and place of the meeting should be provided. An “acknowledgement(s)” section should be placed on the title page to thank those who helped the study or preparation of the manuscript, if any. All funding sources that supported the work and the institutional and/or corporate affiliations of the authors should be acknowledged on the title page. This section contains statements of gratitude for personal, technical or material help, etc. Conflict of interest statement should also be included.
2. Abstract and keywords: All articles should contain an abstract. Authors should include the abstract and the key words in the main text file. Abstracts must be no longer than 250 words. The abstracts should be structured [objective, materials and methods, results and conclusions]. Case reports should also include a structured abstract [objective, case report(s), and conclusion]. Abbreviations and institutional information should not be written in the abstract. The authors should list three to five key words or phrases taken from Index Medicus Medical Subject Headings (http://www.nlm.nih.gov/mesh/MBrowser.html) at the end of this section.
3. Maintext: Original articles should be organized in six main headings: abstract, keywords, introduction, material and method, results, and discussion. Abbreviations should be defined at first mention in the text and in each table and figure. If a brand name is cited, supply the manufacturer’s name and address (city and state/country). Case reports should include the following identifiable sections: abstract, keywords, introduction, case report(s), and discussion.

Figure legends should be included in the main text file after the references.

1. References: References should be arranged according to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” rules developed by “International Committee of Medical Journal Editors (ICMJE)”. Some examples have been provided for frequently used reference types. The http://www.nlm.nih.gov/bsd/ uniform_requirements.html site should be used for guidance on other types of references not provided here. Each reference should be numbered and listed according to their order in the text. They should be referred to in parentheses as “(….)’’ at the end of sentences within the text. The author(s) are responsible for the accuracy of the references. Journal titles should be abbreviated according to Index Medicus. Refer to the “List of Journals Indexed in Index Medicus” for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/ lji.html. Abbreviations are not used for journals that are not listed in the Index Medicus. Only published articles or articles “in press” can be used in references. All authors names must be written, do not use “et al”.

Link for EndNote Style: https://endnote.com/style_download/turkish- journal-of-pathology-turk-patoloji/

Journals:

Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV- infected patients. N Engl J Med. 2002;347:284-7. PMID: 12140307 DOI: 10.1056/NEJMsb020632

Books:

Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.

Book chapters:

Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. 93-113.

Meeting announcements:

Christensen S, Oppacher F. An analysis of Koza’s computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.